Cargando…

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension

BACKGROUND: Late gadolinium enhancement (LGE) occurs at the right ventricular (RV) insertion point (RVIP) in patients with pulmonary hypertension (PH) and has been shown to correlate with cardiovascular magnetic resonance (CMR) derived RV indices. However, the prognostic role of RVIP-LGE and other C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freed, Benjamin H, Gomberg-Maitland, Mardi, Chandra, Sonal, Mor-Avi, Victor, Rich, Stuart, Archer, Stephen L, Jamison, E Bruce, Lang, Roberto M, Patel, Amit R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311144/ https://www.ncbi.nlm.nih.gov/pubmed/22296860 http://dx.doi.org/10.1186/1532-429X-14-11

Ejemplares similares

The role of late gadolinium enhancement of the right ventricular insertion point predicts survival in patients with pulmonary hypertension
por: Freed, Benjamin H, et al.
Publicado: (2011)

Designing pulmonary arterial hypertension trials for detecting change in right ventricular function using cardiovascular magnetic resonance: what is the appropriate sample size?
por: Addetia, Karima, et al.
Publicado: (2013)

Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension
por: Cork, David P., et al.
Publicado: (2012)

Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement
por: Erley, Jennifer, et al.
Publicado: (2019)

Right Heart Catheterization—To Do or Not To Do? Introducing a New Diagnostic Algorithm for Pulmonary Hypertension
por: Ryan, John J., et al.
Publicado: (2022)

Refining risk assessment in cardiac sarcoidosis: a role for burden of late gadolinium enhancement and right ventricular function
por: Murtagh, Gillian, et al.
Publicado: (2014)

Influence of late gadolinium enhancement on left ventricular morphology and function in patients with sarcoidosis
por: Patel, Amit R, et al.
Publicado: (2009)

Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2015)

Author's reply
por: Cork, David P., et al.
Publicado: (2013)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020)

Health disparity is a global issue: Understanding Latin America
por: Gomberg‐Maitland, Mardi, et al.
Publicado: (2022)

Lipid sub-fractionation predicts worsening myocardial perfusion reserve in patients with low-density lipoprotein less than 100mg/dL: a regadenoson dardiac magnetic resonance study
por: Narang, Akhil, et al.
Publicado: (2012)

Late gadolinium enhancement in pulmonary hypertension predicts clinical events
por: Soma, Siva Kumar, et al.
Publicado: (2012)

Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic
por: Ryan, John J., et al.
Publicado: (2020)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance
por: Steadman, Christopher D, et al.
Publicado: (2009)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
por: Addetia, Karima, et al.
Publicado: (2016)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Prognostic value of adenosine stress perfusion cardiac magnetic resonance with late gadolinium enhancement
por: Bertaso, Angela G, et al.
Publicado: (2011)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
por: Strijack, Bradford, et al.
Publicado: (2008)

Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance
por: Lopez, Javier E, et al.
Publicado: (2009)

Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance
por: Quail, Michael, et al.
Publicado: (2019)

CMR RV size assessment should include RV to LV volume ratio
por: Altmayer, Stephan P, et al.
Publicado: (2015)

Implantable system for treprostinil and lung transplantation: case series from delivery for pulmonary arterial hypertension study
por: Feldman, Jeremy P., et al.
Publicado: (2021)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Clinical trial design and new therapies for pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2019)

Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging
por: Huang, Y. Jessica, et al.
Publicado: (2016)

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance
por: Kirk, Paul, et al.
Publicado: (2011)

A comparison of late gadolinium enhancement magnetic resonance imaging and left atrial endocardial voltage
por: Harrison, James, et al.
Publicado: (2013)

Prediction of gaps in atrial ablation lesion sets by late gadolinium enhancement magnetic resonance imaging
por: Harrison, James, et al.
Publicado: (2013)

Unique pattern of late gadolinium enhancement on cardiac magnetic resonance imaging in Duchenne muscular dystrophy
por: Ganigara, Madhusudan, et al.
Publicado: (2016)

Late gadolinium enhancement by cardiovascular magnetic resonance provides prognostic information in symptomatic alcoholic cardiomyopathy
por: Xiangli, Wei
Publicado: (2015)

Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis
por: Sano, Makoto, et al.
Publicado: (2014)

Gray blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of myocardial scar
por: Fahmy, Ahmed S., et al.
Publicado: (2018)

Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy
por: Schelbert, Erik B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ikrsmh4vliup5s3edjmlrh33cp